ARTICLE | Distillery Therapeutics
ISM1 as a therapy for diabetes, fatty liver disease
August 27, 2021 9:10 PM UTC
DISEASE CATEGORY: Endocrine/metabolic; hepatic
INDICATION: Diabetes; liver disease...
BCIQ Company Profiles
BCIQ Target Profiles
DISEASE CATEGORY: Endocrine/metabolic; hepatic
INDICATION: Diabetes; liver disease...
BCIQ Company Profiles
BCIQ Target Profiles